Elmind Capital, LP
Q4 2025 13F Holdings
- Locationnew york, NY
- Num holdings
34
- Value ($000)
$338,852
- Date Filed02/17/2026
- Form type13F-HR
- CIK0002052213
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 to
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
COGENT BIOSCIENCES INC | COM | 19240Q201 | $41.58M | 12 % | 1,170,740 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | $38.97M | 12 % | 1,855,000 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | $26.72M | 8 % | 858,631 | ||
VERA THERAPEUTICS INC | CL A | 92337R101 | $24.43M | 7 % | 482,500 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | $23.49M | 7 % | 865,000 | ||
CG ONCOLOGY INC | COM | 156944100 | $20.45M | 6 % | 492,500 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | $16.77M | 5 % | 2,150,000 | ||
VAXCYTE INC | COM | 92243G108 | $13.45M | 4 % | 291,500 | ||
BEAM THERAPEUTICS INC | COM | 07373V105 | $13.2M | 4 % | 476,338 | ||
PHARVARIS N V | COM | N69605108 | $13.2M | 4 % | 475,750 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100